News
Latest News | A First-In-Class Selective Inhibitor of EGFR and PI3K Offers A Single-Molecule Approach to Targeting Adaptive Resistance
2024-09-11
On July 11, 2024, a team of researchers led by Dr. Judith Sebolt Leopold designed a kinase inhibitor MTX-531 that can block epidermal growth factor receptor (EGFR) and phosphatidylinositol 3-OH kinase (PI3K).
Accelerate Drug Discovery with Biosimilar Antibodies - The Fast Track to Target Binding
2024-04-30
Alpha Lifetech's 700+ biosimilar antibodies target EGFR, TNF-α, VEGF, speeding up drug research with validated quality.
Unlocking the Mysteries of Biological Processes: Alpha Lifetech Produces High-Quality Membrane Proteins for Scientists
2024-04-30
Alpha Lifetech offers quality membrane proteins for drug discovery and cellular insights, using advanced production techniques.
The Art and Science of Nanobody Discovery: How Alpha Lifetech is Pushing Boundaries
2024-04-29
Discover nanobody technology: phage display, immunization, screening, selection, and structural analysis at Alpha Lifetech for diagnostics and therapy.